Cargando…
Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation
We report on a 32-year old female patient with primary antiphospholipid syndrome (PAPS) and several thromboembolic events despite stable doses of oral anticoagulation, good patient compliance and maintained INR values of >3. Over the preceding 3 years the patient had presented a wide spectrum of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102000/ https://www.ncbi.nlm.nih.gov/pubmed/15168158 http://dx.doi.org/10.1007/s10067-004-0864-0 |
_version_ | 1783511733771436032 |
---|---|
author | Miesbach, W. Scharrer, I. Asherson, R. A. |
author_facet | Miesbach, W. Scharrer, I. Asherson, R. A. |
author_sort | Miesbach, W. |
collection | PubMed |
description | We report on a 32-year old female patient with primary antiphospholipid syndrome (PAPS) and several thromboembolic events despite stable doses of oral anticoagulation, good patient compliance and maintained INR values of >3. Over the preceding 3 years the patient had presented a wide spectrum of manifestations of APS, including recurrent venous and arterial thromboses, cardiac, gynecological (HELLP syndrome), neurological involvements, livedo reticularis, a mild thrombocytopenia and the most feared manifestation of the catastrophic antiphospholipid syndrome (CAPS). Life-threatening bilateral subdural bleeding occurred while she was anticoagulated. The clinical features appeared to be refractory to oral anticoagulation with phenprocoumon. They were life threatening on each occasion and she developed repetitive episodes of organ damage with cardiac insufficiency (NYHA III), pulmonary hypertension and other residual defects. Even during heparinization recurrent thromboembolism supervened as well as livedo reticularis of the extremities. Lupus anticoagulants (LAC), anticardiolipin (aCL) antibodies and anti-β(2)-glycoprotein-1 (β(2)GPI) titers were all markedly elevated. This case report shows that recurrent episodes of thrombosis can occur despite seemingly adequate anticoagulation in patients with CAPS. |
format | Online Article Text |
id | pubmed-7102000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-71020002020-03-31 Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation Miesbach, W. Scharrer, I. Asherson, R. A. Clin Rheumatol Case Report We report on a 32-year old female patient with primary antiphospholipid syndrome (PAPS) and several thromboembolic events despite stable doses of oral anticoagulation, good patient compliance and maintained INR values of >3. Over the preceding 3 years the patient had presented a wide spectrum of manifestations of APS, including recurrent venous and arterial thromboses, cardiac, gynecological (HELLP syndrome), neurological involvements, livedo reticularis, a mild thrombocytopenia and the most feared manifestation of the catastrophic antiphospholipid syndrome (CAPS). Life-threatening bilateral subdural bleeding occurred while she was anticoagulated. The clinical features appeared to be refractory to oral anticoagulation with phenprocoumon. They were life threatening on each occasion and she developed repetitive episodes of organ damage with cardiac insufficiency (NYHA III), pulmonary hypertension and other residual defects. Even during heparinization recurrent thromboembolism supervened as well as livedo reticularis of the extremities. Lupus anticoagulants (LAC), anticardiolipin (aCL) antibodies and anti-β(2)-glycoprotein-1 (β(2)GPI) titers were all markedly elevated. This case report shows that recurrent episodes of thrombosis can occur despite seemingly adequate anticoagulation in patients with CAPS. Springer-Verlag 2004-03-20 2004 /pmc/articles/PMC7102000/ /pubmed/15168158 http://dx.doi.org/10.1007/s10067-004-0864-0 Text en © Clinical Rheumatology 2004 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Case Report Miesbach, W. Scharrer, I. Asherson, R. A. Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation |
title | Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation |
title_full | Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation |
title_fullStr | Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation |
title_full_unstemmed | Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation |
title_short | Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation |
title_sort | recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102000/ https://www.ncbi.nlm.nih.gov/pubmed/15168158 http://dx.doi.org/10.1007/s10067-004-0864-0 |
work_keys_str_mv | AT miesbachw recurrentlifethreateningthromboembolismandcatastrophicantiphospholipidsyndromeinapatientdespitesufficientoralanticoagulation AT scharreri recurrentlifethreateningthromboembolismandcatastrophicantiphospholipidsyndromeinapatientdespitesufficientoralanticoagulation AT ashersonra recurrentlifethreateningthromboembolismandcatastrophicantiphospholipidsyndromeinapatientdespitesufficientoralanticoagulation |